Clopidogrel and aspirin in patients with atrial fibrillation - ACTIVE A study (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)

被引：1
|
作者：
Moser, M. [1 ]
Bode, C. [1 ]
Nitschmann, S.
机构：
[1] Univ Freiburg Klinikum, D-79106 Freiburg, Germany
来源：
INTERNIST | 2010年 / 51卷 / 01期
关键词：
D O I：
10.1007/s00108-009-2573-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [21] Warfarin controlled, randomized study of clopidogrel and aspirin for prevention of thromboembolic events in chronic non-valvular atrial fibrillation
    Yigit, Z
    Ökçun, B
    KüçükoÖlu, MS
    EUROPEAN HEART JOURNAL, 2004, 25 : 488 - 488
  • [22] Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR
    Jackson, SL
    Peterson, GM
    Bereznicki, LR
    AMERICAN HEART JOURNAL, 2005, 149 (01)
  • [23] Prevention of vascular events in atrial fibrillation
    Cheng, Huai yong
    LANCET, 2007, 369 (9556): : 105 - 106
  • [24] Clopidogrel hydrogen sulphate for atrial fibrillation
    Garg, Nadish
    Rajpurohit, Naveen
    Flaker, Greg
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1781 - 1787
  • [25] Clopidogrel as antithrombotic therapy in atrial fibrillation
    Veloso, HH
    de Paola, AAV
    CHEST, 2005, 128 (01) : 475 - 475
  • [26] Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR - Reply
    De Caterina, R
    Lorenzoni, R
    AMERICAN HEART JOURNAL, 2005, 149 (01)
  • [27] Antikoagulation bei VorhofflimmernACTIVE-Studie (Aterial fibrillation Clopidogrel Trail with Irbesartan for prevention of Vascular Events)
    T. Meinertz
    Der Internist, 2007, 48 : 874 - 875
  • [28] Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable
    Coleman, Craig I.
    Straznitskas, Andrew D.
    Sobieraj, Diana M.
    Kluger, Jeffrey
    Anglade, Moise W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 1020 - 1025
  • [29] Clopidogrel Plus Aspirin is Cost-Effective for Stroke Prevention in Patients with Atrial Fibrillation in Whom Warfarin is Unsuitable
    Coleman, Craig I.
    Straznitskas, Andrew D.
    Sobieraj, Diana M.
    Kluger, Jeffrey
    CIRCULATION, 2011, 124 (21)
  • [30] Irbesartan in Patients with Atrial Fibrillation
    Yusuf, Salim
    Healey, Jeff S.
    Pogue, Janice
    Chrolavicius, Susan
    Flather, Marcus
    Hart, Robert G.
    Hohnloser, Stefan H.
    Joyner, Campbell D.
    Pfeffer, Marc A.
    Connolly, Stuart J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 928 - 938
12345